mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-05 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |